Profil
Andrew Turner is the founder of BioRexis Pharmaceutical Corp.
which was founded in 2002.
He also worked as a Director-Technology Development at PhaseBio Pharmaceuticals, Inc. and as a Principal at Principia Pharmaceutical Corp.
Anciens postes connus de Andrew Turner
| Sociétés | Poste | Fin |
|---|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Fondateur | - |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and biopharmaceuticals for serious chronic diseases | Corporate Officer/Principal | - |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
PhaseBio Pharmaceuticals, Inc.
PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and biopharmaceuticals for serious chronic diseases | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Health Technology |
















